Sotelix Endoscopy, a medical device startup developing next-generation therapeutic endoscopy devices, announced the closing of a $1.7 million seed round financing. The investment will fund the company’s research and development efforts, including in vivo testing of its innovative device.
The funding round included investments from individual investors, including some of the world’s leading endoscopists, experienced medical device entrepreneurs, and other investors with clinical, technical, and business expertise.
Sotelix Endoscopy was created by Dr. Mouen Khashab, a Professor of Medicine at Johns Hopkins University School of Medicine and one of the world’s leading endoscopists. And the leadership team includes co-founder Dr. Venkata Akshintala, an associate professor at Johns Hopkins University School of Medicine and pioneer in gastrointestinal medical device development; chairman Mohamad Khachab, a successful entrepreneur and investor; and CEO John Schellhorn.
KEY QUOTE:
“Therapeutic endoscopy holds the potential to treat numerous gastrointestinal conditions in a minimally invasive manner, but achieving this requires the right tools. Sotelix is dedicated to creating these tools to enable incision-free, scar-free treatments, helping patients return to their lives faster.”
– Dr. Mouen Khashab, founder of Sotelix Endoscopy and Director of Therapeutic Endoscopy at Johns Hopkins Medicine
